Business Context and Reporting Period
This Form 6-K filing by Novo Nordisk A/S, dated November 14, 2025, reports on the resolutions adopted at an Extraordinary General Meeting held on that date. The meeting was convened specifically to elect new members to the Board of Directors. Novo Nordisk is a global healthcare company headquartered in Denmark, employing approximately 78,500 people across 80 countries.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is a complete restructuring of the Board of Directors leadership and composition:
- Departures: Helge Lund (Chair), Henrik Poulsen (Vice Chair), and board members Laurence Debroux, Andreas Fibig, Sylvie Grégoire, Christina Law, and Martin Mackay stepped down.
- Appointments: Lars Rebien Sørensen was elected as the new Chair of the Board. Cees de Jong was elected as Vice Chair. Britt Meelby Jensen and Stephan Engels were elected as new Board members.
- Term: All new elections are effective until the next Annual General Meeting on March 26, 2026.
Guidance, Outlook, and Management Commentary
Lars Rebien Sørensen, the newly elected Chair, outlined two primary mandates for the Board:
- Support the CEO and management in transformation plans to regain competitive leadership.
- Prepare the way for his own successor.
Sørensen emphasized his commitment to attending to the interests of all shareholders, including minority shareholders, and expressed a desire to engage in dialogue to understand their views. The filing does not provide specific financial guidance, risk factors, or contingencies related to operations.
Key Facts for Investor Verification
- Verify the effective date of the new Board composition and committee assignments.
- Confirm the timeline for the "transformation plans" mentioned by the new Chair to regain competitive leadership.
- Monitor upcoming communications regarding the search for Lars Rebien Sørensen's successor.
- Check subsequent filings for the next Annual General Meeting scheduled for March 26, 2026.